Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CRMXX vs. MRSAX: which is better?

Bottom line

CRMXX vs MRSAX: the short answer

CRMXX (MFS U.S. Government Cash Reserve Fund) and MRSAX (MFS Research International Fund) are both money market funds.

CRMXX is cheaper at 0.45% vs 0.99% — a difference of $54 a year per $10,000 invested.

Over five years, MRSAX returned +2.6% a year vs +2.1% for CRMXX.

MRSAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

CRMXX vs MRSAX side by side

CRMXXMRSAX
TypeMoney market fundMutual fund
Fund familyMFSMFS
CategoryMoney MarketInternational Stock
Expense ratio0.45%0.99%
Annual cost per $10k$45$99
10-yr cost on $10k (prospectus)$1,260$1,728
Max front load0%5.75%
12b-1 fee0.5%0.25%
1-yr return+4.9%−3.1%
5-yr return (annualized)+2.1%+2.6%
10-yr return (annualized)+1.4%+4.5%
Best quarter—+16.5%
Worst quarter—−19.7%
Net assets (fund)—$17.8B
Number of holdings—121
Portfolio turnover—27%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CRMXX and MRSAX share none of their top holdings.

CRMXX top 10

    MRSAX top 10

    1. Mizuho Financial Group Inc — 2.90%
    2. Schneider Electric SE — 2.82%
    3. Hitachi Ltd — 2.45%
    4. ASML Holding NV — 2.21%
    5. Taiwan Semiconductor Manufacturing Co Ltd — 2.21%
    6. Novartis AG — 2.12%
    7. TotalEnergies SE — 2.10%
    8. Tokyo Electron Ltd — 1.90%
    9. AstraZeneca PLC — 1.78%
    10. Linde PLC — 1.76%

    FAQ

    What is the difference between CRMXX and MRSAX?
    CRMXX (MFS U.S. Government Cash Reserve Fund) and MRSAX (MFS Research International Fund) are both money market funds. CRMXX is cheaper at 0.45% vs 0.99% — a difference of $54 a year per $10,000 invested.
    Which is cheaper, CRMXX or MRSAX?
    CRMXX has the lower expense ratio (0.45%).
    Should I own both CRMXX and MRSAX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.